Serological assay and genotyping of hepatitis C virus in infected patients in Zanjan Province

Hepatitis Monthly

Volumn 14, Issue 9, 2014, Pages

  Esmaeilzadeh, Abdolreza ^a,b   Erfanmanesh, Maryam ^c   Ghasemi, Sousan ^d   Mohammadi, Farzaneh ^a  

^a ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti HCV antibody; AS PCR; Genotype; Hepatitis C virus; RT PCR

Indexed keywords

VIRUS ANTIBODY;

ALLELE; ARTICLE; BIOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL ELECTROPHORESIS; GENE FREQUENCY; GENE IDENTIFICATION; GENOTYPE; GENOTYPING TECHNIQUE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84907821994     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.17323     Document Type: Article

References (41)

1. Aalaei-Andabili SH, Behnava B, Salimi S, Sharaf H, Alavian SM. Mysterious Linkages Between Hepatitis C Virus Genotypes, In-terleukin-28B Genotypes and Viral Clearance- A Meta-Analysis. Hepat Mon. 2014;14(3).
2. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Mi-crobiol Infect. 2011;17(2):107–15.
3. Martin NK, Vickerman P, Foster GR, Hutchinson SJ, Goldberg DJ, Hickman M. Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. J Hepatol. 2011;54(6):1137–44.
4. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345(1):41–52.
5. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med. 2005;8(2):84–90.
6. Piluso A, Giannini C, Fognani E, Gragnani L, Caini P, Monti M, et al. Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia: results of a large, prospective study. J Viral Hepat. 2013;20(4):e107–14.
7. Aleman S, Rahbin N, Weiland O, Davidsdottir L, Hedenstierna M, Rose N, et al. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis. Clin Infect Dis. 2013;57(2):230–6.
8. Ziyaeyan M, Alborzi A, Jamalidoust M, Badiee P, Moeini M, Kadi-var A. Prevalence of hepatitis C virus genotypes in chronic infected patients, southern Iran. Jundishapur J Microbiol. 2011;4(3):141–6.
9. Farnik H, Mihm U, Zeuzem S. Optimal therapy in genotype 1 patients. Liver Int. 2009;29 Suppl 1:23–30.
10. Daw MA, Elasifer HA, Dau AA, Agnan M. The role of hepatitis C virus genotyping in evaluating the efficacy of INF-based therapy used in treating hepatitis C infected patients in Libya. Virol Dis-cov. 2013;1(3):1–8.
11. Abuelhassan W. Hepatitis C virus infection in 2012 and beyond. South Afr J Epidemiol Infect. 2012;27(3):93–7.
12. Kamal SM. Hepatitis C genotype 4 therapy: increasing options and improving outcomes. Liver Int. 2009;29 Suppl 1:39–48.
13. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat. 2002;9(5):390–2.
14. Tajbakhsh E, Dosti A, Tajbakhsh S, Momeni M, Tajbakhsh F. Determination of hepatitis C virus genotypes among HCV positive patients in Shahrekord, Iran. Afr J Microbiol Res. 2011;5(32):5910–5.
15. Smith DB, Bukh J, Kuiken C, Muerhof AS, Rice CM, Stapleton JT, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59(1):318–27.
16. Doerrbecker J, Meuleman P, Kang J, Riebesehl N, Wilhelm C, Friesland M, et al. Thermostability of seven hepatitis C virus genotypes in vitro and in vivo. J Viral Hepat. 2013;20(7):478–85.
17. Shawa IT, Hopkins M. Evaluation of Hepatitis C Virus Geno-typing Protocols for Use in a Diagnostic Setting. Int J Med Res. 2013;1(1):2–7.
18. Sam SS, Steinmetz HB, Tsongalis GJ, Tafe LJ, Leferts JA. Validation of a solid-phase electrochemical array for genotyping hepatitis C virus. Exp Mol Pathol. 2013;95(1):18–22.
19. Gonzalez V, Gomes-Fernandes M, Bascunana E, Casanovas S, Salu-des V, Jordana-Lluch E, et al. Accuracy of a commercially available assay for HCV genotyping and subtyping in the clinical practice. J Clin Virol. 2013;58(1):249–53.
20. Cenci M, Massi M, Alderisio M, De Soccio G, Recchia O. Prevalence of hepatitis C virus (HCV) genotypes and increase of type 4 in central Italy: an update and report of a new method of HCV ge-notyping. Anticancer Res. 2007;27(2):1219–22.
21. Zein NN. Clinical signifcance of hepatitis C virus genotypes. Clin Microbiol Rev. 2000;13(2):223–35.
22. Hajia M, Amirzargar A, Khedmat H, Shahrokhi N, Farzanehkhah M, Ghorishi S, et al. Genotyping Pattern among Iranian HCV Positive Patients. Iran J Public Health. 2010;39(2):39–44.
23. Bae AS, Ku KS, Miller MD, Mo H, Svarovskaia ES. Allele-specifc real-time PCR system for detection of subpopulations of genotype 1a and 1b hepatitis C NS5B Y448H mutant viruses in clinical samples. J Clin Microbiol. 2011;49(9):3168–74.
24. Nakatani SM, Santos CA, Riediger IN, Krieger MA, Duarte CA, do Carmo Debur M, et al. Comparative performance evaluation of hepatitis C virus genotyping based on the 5' untranslated region versus partial sequencing of the NS5B region of brazilian patients with chronic hepatitis C. Virol J. 2011;8:459.
25. MirDavood O, Khadem AMH. Hepatitis c virus genotyping by melting curve analysis in west azerbaijan, northwest of IRAN. Hepat Mon. 2009;9(2):133–6.
26. Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Nasseri S. Distribution of hepatitis C virus genotypes among azerbaijani patients in capital city of iran-tehran. Hepat Mon. 2013;13(9).
27. Jahanbakhsh Sefdi F, Keyvani H, Monavari SH, Alavian SM, Fakh-im S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013;13(1).
28. Zarkesh Esfahani SH, Kardi MT, Edalati M. Hepatitis C virus genotype frequency in Isfahan province of Iran: a descriptive cross-sectional study. Virol J. 2010;7(69):1–6.
29. Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, et al. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study. J Med Virol. 2006;78(5):569–73.
30. Nguyen MH, Keefe EB. Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9. Rev Gastroenterol Disord. 2004;4 Suppl 1:S14–21.
31. Qadi AA, Tamim H, Ameen G, Bu-Ali A, Al-Arrayed S, Fawaz NA, et al. Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control. 2004;32(8):493–5.
32. Mousavi SF, Moosavy SH, Alavian SM, Eghbali H, Mahboobi H. Distribution of hepatitis C virus genotypes among patients with hepatitis C virus infection in hormozgan, iran. Hepat Mon. 2013;13(12).
33. Akhtar S, Moatter T, Azam SI, Rahbar MH, Adil S. Prevalence and risk factors for intrafamilial transmission of hepatitis C virus in Karachi, Pakistan. J Viral Hepat. 2002;9(4):309–14.
34. Lole KS, Jha JA, Shrotri SP, Tandon BN, Prasad VG, Arankalle VA. Comparison of hepatitis C virus genotyping by 5' noncoding region- and core-based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India. J Clin Microbiol. 2003;41(11):5240–4.
35. Singh S, Malhotra V, Sarin SK. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in India. Indian J Med Res. 2004;119(4):145–8.
36. Zhang L, Chen Z, Cao Y, Yu J, Li G, Yu W, et al. Molecular characterization of human immunodefciency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china. J Virol. 2004;78(24):13591–9.
37. Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol. 2005;75(4):538–49.
38. Mohsen AH, Trent HCVSG. The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut. 2001;48(5):707–13.
39. Thomson BJ, Finch RG. Hepatitis C virus infection. Clin Microbiol Infect. 2005;11(2):86–94.
40. Gonzaga RM, Rodart IF, Reis MG, Ramalho Neto CE, Silva DW. Distribution of Hepatitis C virus (HCV) genotypes in sero-positive patients in the state of Alagoas, Brazil. Braz J Microbiol. 2008;39(4):644–7.
41. Ramia S, Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis. 2006;10(4):272–7.